Agronomics Capital

www.agronomics.im

VCMatch tracks Agronomics Capital as an investor focused on Biotech, Foodtech, and Agtech companies, Seed and Series A rounds, and United Kingdom, Europe, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A, Series B, Growth, Late Stage

Focus Areas

Biotech, Foodtech, Agtech

Geography

United Kingdom, Europe, and Global

Investment Thesis

Agronomics positions itself as a specialist investor in “clean food,” arguing that “Conventional agriculture isn’t just unsustainable – it’s no longer financially viable.” The firm backs companies that use biotechnology (cell culture, precision fermentation and related enabling infrastructure) to produce proteins, fats and tissues with fewer resources, less waste and improved food security, aiming to generate capital growth for shareholders by transforming large, inefficient parts of the conventional food market.

Is Agronomics Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Agronomics Capital is most relevant for founders raising Seed, Series A, and Series B rounds in Biotech, Foodtech, Agtech, and Manufacturing, especially across United Kingdom, Europe, and Global.

Focus statement

A London-listed investment company focused on clean food: primarily cell culture (cultivated meat/plant cell products), precision fermentation (recombinant proteins/dairy/egg analogues) and the enabling biomanufacturing technologies (scale-up infrastructure) required to commercialise those technologies.

Value Add

Listed vehicle providing individual investors “Access clean agriculture companies through a single, publicly traded stock.”
Explicit dual focus on both upstream biological technologies (cell culture, precision fermentation) and downstream enabling infrastructure (biomanufacturing/fermentation facilities and scale-up).
Invests across quoted and unquoted companies (equity and equity-related products) to capture liquidity and upside: “investing in equity and equity related products in both quoted companies... and in unquoted companies.”
Strong governance framework (QCA Code) and emphasis on delivering shareholder value via capital growth and selective realisations.
Portfolio-stage involvement and board/portfolio-management overlap (founders and directors sit on portfolio company boards), showing hands-on portfolio governance.